Table 4.
Using Aβ42, t-Tau and p-Tau for classification | Using Aβ42/40 ratio, t-Tau and p-Tau for classification | |
---|---|---|
LL | 4/40 (10%) | 3/38 (8%) |
IAP | 7/16 (44%) | 8/18 (44%) |
SNAP | 20/36 (56%) | 9/17 (53%) |
HL | 39/52 (75%) | 50/71 (72%) |
Data are expressed as n/total (percentage) of patients
AD Alzheimer’s disease, MCI mild cognitive impairment, Aβ42 42-aminoacid isoform of amyloid beta, t-Tau total Tau protein, p-Tau hyperphosphorylated Tau protein, Aβ40 40-aminoacid isoform of amyloid beta, LL low-AD likelihood, IAP isolated amyloid pathology, SNAP suspected non-Alzheimer pathology, HL High-AD likelihood